PRQR — ProQR Therapeutics N.V.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1612940 · Netherlands
Last close
$1.65
Market Cap
$232.85M
52W High
$3.10
52W Low
$1.33
ADV30
813,351
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 8,759,000 — -8,822,000 -8,728,000 133,553,000 117,125,000 54,076,000
Mar 2026 2,033,000 — -13,649,000 -13,383,000 99,034,000 81,088,000 61,436,000
Dec 2025 4,688,000 — -9,097,000 -8,920,000 112,756,000 92,413,000 63,382,000
Sep 2025 2,882,000 — -11,284,000 -11,006,000 124,349,000 106,883,000 67,278,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-48,138,000
Investing CF
$-960,000
Financing CF
$-1,640,000
CapEx
$-960,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.45
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-478,894,000
Inventory
—
Receivables
$5,894,000
ST Investments
—
EBIT TTM
$-44,069,000
Pretax Income TTM
$-45,469,000
Interest Exp TTM
—
Analysts
8

Yahoo Snapshot (yfinance, live)

Total Revenue
$18,423,000
EBITDA
$-41,902,000
Free Cash Flow
$-19,073,124
Enterprise Value
$102,710,024
Total Cash
$117,125,000
Total Debt
$15,312,000
Shares Out
141,119,032
Trailing EPS
$-0.47
Book Value
$0.84
ROE
-57.4%
ROA
-19.8%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 15,906,000 -43,446,000 -42,184,000 112,756,000 63,382,000 49,374,000 -52,791,000
Dec 2024 18,905,000 -30,472,000 -27,763,000 167,958,000 79,398,000 88,560,000 -36,393,000
Dec 2023 6,514,000 -34,790,000 -28,119,000 137,883,000 96,493,000 41,390,000 21,548,000
Dec 2022 3,594,000 -65,159,000 -64,424,000 171,321,000 104,640,000 67,065,000 -68,508,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.47

Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $1.00 · spot: $1.65 · call volume: 72 · put volume: 0

Peers — same industry

TickerNameMarket CapLastDaily %
SION Sionna Therapeutics, Inc. $231.17M $5.12 —
SLGL Sol-Gel Technologies Ltd. $227.38M $69.45 —
LYEL Lyell Immunopharma, Inc. $238.68M $9.74 —
NATR NATURES SUNSHINE PRODUCTS INC $225.75M $12.83 —
CAMP Camp4 Therapeutics Corp $241.60M $3.85 —

News headlines (Yahoo Finance, 1h cache)

ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor
2026-09-23 12:00 · Yahoo
ProQR to Participate in Upcoming Investor Conferences in September 2026
2026-09-02 12:00 · Yahoo
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
2026-06-25 10:35 · Yahoo
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
2026-06-25 10:25 · Yahoo
ProQR Therapeutics N.V. (NASDAQ:PRQR) Analysts Just Slashed This Year's Revenue Estimates By 22%
2026-05-14 12:25 · Yahoo
ProQR Announces First Quarter 2026 Operating and Financial Results
2026-05-12 11:00 · Yahoo
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform
2026-05-11 12:00 · Yahoo
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
2026-05-04 12:00 · Yahoo
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors
2026-04-30 12:00 · Yahoo
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
2026-04-08 20:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.